|
Volumn 6, Issue 2, 1999, Pages 127-130
|
Proceedings of the International Symposium on Aromatase and its Inhibitors: New Biology and Clinical Perspectives. 3-6 September 1998, Prague, Czech Republic: Editorial
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANASTROZOLE;
ANTIESTROGEN;
AROMATASE;
AROMATASE INHIBITOR;
CYCLIC AMP;
CYTOCHROME P450;
ESTROGEN;
ESTROGEN RECEPTOR;
EXEMESTANE;
FULVESTRANT;
INTERLEUKIN 6;
LETROZOLE;
PROSTAGLANDIN E2;
TAMOXIFEN;
TUMOR NECROSIS FACTOR ALPHA;
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
ALBRIGHT SYNDROME;
BREAST CANCER;
BREAST HYPERPLASIA;
CANCER RISK;
CANCER SUSCEPTIBILITY;
EDITORIAL;
ENDOMETRIOSIS;
ENZYME ACTIVITY;
ESTROGEN SYNTHESIS;
GENITAL TRACT CANCER;
GYNECOMASTIA;
HUMAN;
NONHUMAN;
POSTMENOPAUSE;
PRECOCIOUS PUBERTY;
ARTICLE;
BREAST TUMOR;
METABOLISM;
NEOPLASM;
ANTINEOPLASTIC AGENTS;
AROMATASE;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
ENZYME INHIBITORS;
ESTROGENS;
HUMANS;
NEOPLASMS, HORMONE-DEPENDENT;
|
EID: 0033043186
PISSN: 13510088
EISSN: None
Source Type: Journal
DOI: 10.1677/erc.0.006a127 Document Type: Editorial |
Times cited : (7)
|
References (0)
|